vTv Therapeutics's Stock Price And Volume Action
vTv Therapeutics's VTVT stock has been rising Tuesday, up 33.65% to a price of $3.32. Tuesday the stock has been traded at a volume of 47.25 million, about 4825.45% of its recent 30-day volume average of 979.17 thousand.
Why It's Moving
Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: VTv Therapeutics shares are trading higher after the company announced that the FDA has granted Breakthrough Therapy designation for TTP399 as an adjunctive therapy to insulin for the treatment of type 1 diabetes.
Further Analysis of Recent Price Action
The 50-day moving average price of vTv Therapeutics's stock was $2.63 when this article was published. The stock reached a high of $4.75 and a low of $1.44 in the past 52 weeks.
Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.